Switzerland
  • Europe
    • FR
    • DE
    • IT
    • ES
    • BE
    • NL
    • LU
    • DK
    • PL
    • UK
  • Switzerland
    • Basel
    • Bern
    • Geneva
    • Lausanne
    • Zürich
  • Schweiz
  • Suisse
  • Alps
  • Business
    • ABB
    • Chubb
    • Glencore
    • Nestlé
    • Novartis
    • Roche
    • UBS
    • Vitol
    • Zurich Insurance
  • NATO
  • US
  • UK
  • Africa
  • Afrique
  • CH

Categories

  • ABB
  • Alps
  • Basel
  • Bern
  • Chubb
  • Geneva
  • Glencore
  • Lausanne
  • Nestlé
  • Novartis
  • Roche
  • Switzerland
  • UBS
  • Vitol
  • Zürich
  • Zurich Insurance
Switzerland
  • Europe
    • FR
    • DE
    • IT
    • ES
    • BE
    • NL
    • LU
    • DK
    • PL
    • UK
  • Switzerland
    • Basel
    • Bern
    • Geneva
    • Lausanne
    • Zürich
  • Schweiz
  • Suisse
  • Alps
  • Business
    • ABB
    • Chubb
    • Glencore
    • Nestlé
    • Novartis
    • Roche
    • UBS
    • Vitol
    • Zurich Insurance
  • NATO
  • US
  • UK
  • Africa
  • Afrique
  • CH

Browsing Tag

Thomas Schinecker

27 posts
RRoche
Roche works to mitigate US tariff impact with exemption plea
Read More

Roche works to mitigate US tariff impact with exemption plea

  • 2026-08-15
Roche is working to mitigate potential impacts from tariffs by moving production of its medicines to the U.S.…
RRoche
Roche Cuts Generic Sales Hit to $736 Million, Shares Jump 3.2%
Read More

Roche Cuts Generic Sales Hit to $736 Million, Shares Jump 3.2%

  • 2026-07-24
This article first appeared on GuruFocus. Roche Holding AG (RHHBF), a Swiss drugmaker, has reduced the amount of…
RRoche
Roche Reaffirms 2026 Outlook Despite Weak Vabysmo Sales, Strong Swiss Franc
Read More

Roche Reaffirms 2026 Outlook Despite Weak Vabysmo Sales, Strong Swiss Franc

  • 2026-07-24
Basel: Swiss ​drugmaker Roche confirmed its 2026 outlook ​on Thursday after first-half sales fell slightly in Swiss ​franc…
RRoche
Roche Cuts Generic Sales Hit to $736 Million, Shares Jump 3.2%
Read More

Roche Cuts Generic Sales Hit to $736 Million, Shares Jump 3.2%

  • 2026-07-24
This article first appeared on GuruFocus. Roche Holding AG (RHHBF), a Swiss drugmaker, has reduced the amount of…
RRoche
Roche CEO Schinecker Warns Swiss Pharma Is Losing Its Edge as $15.2 Billion China Deals Redraw the Map — BigGo Finance
Read More

Roche CEO Schinecker Warns Swiss Pharma Is Losing Its Edge as $15.2 Billion China Deals Redraw the Map — BigGo Finance

  • 2026-07-06
Novo Nordisk just launched the most commercially successful weight-loss drug in history — and it costs less per…
RRoche
Roche contends with loss of momentum for key medicines, currency fluctuations in Q3 but keeps growth on track
Read More

Roche contends with loss of momentum for key medicines, currency fluctuations in Q3 but keeps growth on track

  • 2026-06-18
Even as Roche executives on Thursday espoused confidence in the company’s resilience and growth potential over the next…
RRoche
Roche CEO weighs direct-to-consumer drug sales to ease US drug pricing woes, cut out middlemen
Read More

Roche CEO weighs direct-to-consumer drug sales to ease US drug pricing woes, cut out middlemen

  • 2026-06-18
With high drug prices remaining an ongoing concern for U.S. politicians, Roche is considering following in the footsteps…
RRoche
Roche CEO Expects Pharma Portfolio to Deliver Sales Growth Through 2030
Read More

Roche CEO Expects Pharma Portfolio to Deliver Sales Growth Through 2030

  • 2026-05-24
Roche ROP 2.42%increase; green up pointing triangle Holding expects drugs it already has on the market and a…
RRoche
Roche announces positive phase III results for Gazyva/Gazyvaro in primary membranous nephropathy, marking a significant milestone in this autoimmune disease
Read More

Change to the Roche Enlarged Corporate Executive Committee

  • 2026-04-30
F. Hoffmann-La Roche Ltd Basel, 17 February 2026 – Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced the…
RRoche
Roche Expects Blockbuster Cancer Pill Launch by Year End
Read More

Roche Expects Blockbuster Cancer Pill Launch by Year End

  • 2026-04-23
Roche Holding AG expects to launch the breast cancer pill that may become one of its biggest sellers…
SSwitzerland
Roche shares drop after oral breast cancer drug trial
Read More

Roche CEO laments Swiss franc strength, continues U.S. investment

  • 2026-04-23
Roche reported falling sales in the first three months of the year, as the strength of the Swiss…
RRoche
Roche (ROG) Raises Annual Profit Forecast as New Drugs Buoy Sales
Read More

Roche (ROG) Raises Annual Profit Forecast as New Drugs Buoy Sales

  • 2026-04-19
Roche Holding AG raised its 2024 profit forecast as new drugs like Vabysmo for eye disease drove revenue…
Switzerland
www.europesays.com